Showing 1361-1370 of 23064 results for "".
AEGEAN Trial: The Role of Perioperative Durvalumab in NSCLC
https://reachmd.com/programs/project-oncology/aegean-trial-the-role-of-perioperative-durvalumab-in-nsclc/16500/Explore the results of the AEGAN trial that focused on the use of neoadjuvant durvalumab in non-small cell lung cancer care.Smarter Screening for Non-Small Cell Lung Cancer
https://reachmd.com/programs/project-oncology/smarter-screening-for-non-small-cell-lung-cancer/49129/Early detection of non-small cell lung cancer can save lives, but more testing isn’t always better. By focusing on changes in baseline symptoms, ensuring appropriate follow-up imaging, and applying screening to the right high-risk patients, clinicians can avoid both delays and unnecessary scans. TunBeyond the Surface: Advanced Techniques in Wound Assessment and Care
https://reachmd.com/programs/clinicians-roundtable/beyond-the-surface-advanced-techniques-in-wound-assessment-and-care/35840/Effective wound care goes far beyond just surface evaluation. This expert-led program explores advanced wound assessment strategies, including measurement techniques, drainage evaluation, and recognition of signs of infection. Tune in to hear from Ms. Kara Couch as she explores best practices for opAssessing Anticoagulants & Antiplatelets During GI Bleeding
https://reachmd.com/programs/gi-insights/assessing-anticoagulants-antiplatelets-during-gi-bleeding/13669/Learn how to manage anticoagulants and antiplatelets during acute gastrointestinal bleeding.Dr. Jennifer Nuzzo Answers Even More of Your COVID-19 Questions
https://reachmd.com/programs/public-health-call/dr-jennifer-nuzzo-answers-even-more-of-your-covid-19-questions/11483/Get all of your COVID-19 questions answered by an expert from the Johns Hopkins Center for Health Security.State-of-Art Therapies for ADHD: What Pills Can't Fix
https://reachmd.com/programs/updates-from-mayo-clinic/state-of-art-therapies-for-adhd-what-pills-cant-fix/6748/What are the guidelines from the American Academy of Pediatrics? And, how do we implement these guidelines in our clinical settings? Laurel Leslie, MD joins host, Peter Jensen, MD. Dr. Leslie specializes in the identification and treatment of children with ADHD in primary care settings, and the useNon-pharmacologic Approaches to the Metabolic Syndrome and Diabetes
https://reachmd.com/programs/lipid-luminations/non-pharmacologic-approaches-to-the-metabolic-syndrome-and-diabetes/6704/Why is metabolic syndrome so important if it's not a disease? What have we learned from clinical trials about treating metabolic syndrome with lifestyle and/or drugs? And, what hurdles does the clinician face in trying to improve metabolic syndrome variables in the individual patient? Join Host Dr.Venous Thromboembolism Management and Antithrombotic Therapy in Long-Term Care
https://reachmd.com/programs/advances-in-long-term-care-medicine/venous-thromboembolism-management-and-antithrombotic-therapy-in-long-term-care/6396/Patients in hospital settings are often screened and promptly treated for venous thromboembolism, or VTE, but perhaps less commonly in long-term care, even though these patients may be at risk. Dr. T.S. Dharmarajan, clinical director of the division of geriatrics at Montefiore Medical Center (NorthOrphan Drug Act: 25 Years of Treating Rare Illnesses
https://reachmd.com/programs/clinicians-roundtable/orphan-drug-act-25-years-of-treating-rare-illnesses/3030/Not all drug companies are in pursuit of billion-dollar blockbuster drugs taken by millions of Americans. In fact, there are drugs treating rare conditions that wouldn't be sold on the market if not for a landmark piece of legislation known as the Orphan Drug Act, now 25 years old. Jeffrey Aronin, pEthical Issues Arising in Natural Disasters
https://reachmd.com/programs/focus-on-disaster-medicine-and-preparedness/ethical-issues-arising-in-natural-disasters/1533/Dr. Maurie Pickard speaks with Dr. Michael Brannigan, Vice President of Clinical and Organizational Ethics at the Center for Practical Bioethics in Kansas City, about some of the ethical issues facing medical practitioners during natural disasters. These issues are approached from the macro (federal